Author

Samuel L. James

University of Auckland

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:organoid / primary culture· 1 Assay:proteomics· 1

Frequent Co-Authors

Antonia J. A. RaaijmakersiD· 1 shared Claire L. CurliD· 1 shared DAVID J. TAYLORiD· 1 shared Enzo R. PorrelloiD· 1 shared Gabriel B. BernasochiiD· 1 shared James E. HudsoniD· 1 shared James R. BelliD· 1 shared Jennifer E. Van EykiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Antonia J. A. RaaijmakersORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeted glycophagy ATG8 therapy reverses diabetic heart disease in mice and in human engineered cardiac tissues

Kimberley M. Mellor, Upasna Varma, Parisa Koutsifeli, Claire L. Curl, Johannes V. Janssens, Lorna J. Daniels, Gabriel B. Bernasochi, Antonia J. A. Raaijmakers, Marco Annandale, X. Li, Samuel L. James, DAVID J. TAYLOR, Koen Raedschelders, Kate L. Weeks, Richard J. Mills, , Lea M.D. Delbridge

This study identifies glycophagy dysregulation as a mechanism of diabetic heart disease and shows that Gabarapl1 gene therapy improves cardiac function in diabetic mice and human cardiac organoids.

Nature Cardiovascular Research · Sep 29, 2025Peer-reviewedPhysiology